Prostate-specific antigen

Results: 489



#Item
201Prostate cancer / Prostate / Cancer / Screening / ZERO—The Project to End Prostate Cancer / Prostate-specific antigen / Medicine / Oncology / Cancer screening

RESOLUTION WHEREAS, prostate cancer is the most commonly diagnosed nonskin cancer in men and the second leading cause of cancer death in men. Approximately 1 in 36 men die of prostate cancer; and WHEREAS, prostate cancer

Add to Reading List

Source URL: www.governor.ohio.gov

Language: English - Date: 2014-09-15 11:32:02
202Andrology / Biomarkers / Prostate-specific antigen / Management of prostate cancer / Prostate cancer / Prostate biopsy / Prostate brachytherapy / Prostate / Prostate cancer screening / Medicine / Biopsy / Tumor markers

SONABLATE® 450 FOR THE TREATMENT OF LOCALLY RECURRENT PROSTATE CANCER PMA P130002

Add to Reading List

Source URL: www.fda.gov

Language: English
203Papillomavirus / Medical tests / Rectum / Prostate cancer screening / Pap test / Cervical cancer / Prostate cancer / Screening / Prostate-specific antigen / Medicine / Gynaecological cancer / Cancer screening

Medicare National Coverage Determinations Manual

Add to Reading List

Source URL: www.cms.gov

Language: English - Date: 2013-11-22 11:26:08
204Health promotion / Breast cancer / Prostate cancer / Chronic / Screening / Prostate-specific antigen / Health equity / Center for Managing Chronic Disease / Medicine / Medical terms / Cancer screening

The H aw a i i Behavioral R i s k Factor Surveillance System[removed]RESULTS[removed]revision) Dung-Hanh Nguyen, B.Sc.

Add to Reading List

Source URL: health.hawaii.gov

Language: English - Date: 2014-09-11 21:37:52
205Prostate cancer / Prostate / Cancer / Screening / ZERO—The Project to End Prostate Cancer / Prostate-specific antigen / Medicine / Oncology / Cancer screening

RESOLUTION WHEREAS, prostate cancer is the most commonly diagnosed nonskin cancer in men and the second leading cause of cancer death in men. Approximately 1 in 36 men die of prostate cancer; and WHEREAS, prostate cancer

Add to Reading List

Source URL: governor.ohio.gov

Language: English - Date: 2014-09-15 11:32:02
206Urology / Tumor markers / Prostate-specific membrane antigen / PC3 / Prostate cancer / Immunotoxin / DU145 / Immunotherapy / Medicine / Cancer research / Cell lines

Anti-PSMA Immunotoxins Novel Targeted Therapeutics for Prostate Cancer Albert-Ludwigs-Universität Freiburg Technology The Prostate Specific Membrane Antigen (PSMA) has been proven to be an excellent target for prostate

Add to Reading List

Source URL: www.zft.uni-freiburg.de

Language: English - Date: 2011-06-06 07:53:00
207T cells / Monoclonal antibodies / Oncology / Prostate-specific membrane antigen / Lymphocyte / Prostate cancer / PC3 / Immunotherapy / Cancer immunotherapy / Medicine / Immunology / Immune system

Bispecific PSMAxCD3 Diabody Novel Immunotherapeutic Agent for Prostate Cancer Albert-Ludwigs-Universität Freiburg Technology

Add to Reading List

Source URL: www.zft.uni-freiburg.de

Language: English - Date: 2011-06-06 07:34:29
208Histopathology / Prostate cancer / Dutasteride / Finasteride / Benign prostatic hyperplasia / Prostate-specific antigen / High-grade prostatic intraepithelial neoplasia / Prostate / Urinary retention / Medicine / Lactams / Cancer screening

Avodart Prostate Cancer Risk Reduction Briefing Document

Add to Reading List

Source URL: www.fda.gov

Language: English
209Healthcare reform in the United States / Cancer screening / Prostate cancer screening / Healthcare in Canada / Health economics / Patient safety / Prostate-specific antigen / Prostate cancer / Guided Care / Medicine / Health / Medical terms

____ PSA Patient Safety America Newsletter July 2013

Add to Reading List

Source URL: safepatientproject.org

Language: English - Date: 2014-04-18 12:11:15
210Prostate cancer / Tumor markers / Prostate-specific antigen / Prostate / Merck & Co. / Food and Drug Administration / Cancer / Prostate cancer screening / Medicine / Lactams / Finasteride

NDA[removed]s034: Proscar® (finasteride 5 mg tablet) Indication: No new indication proposed Applicant: Merck and Co., Inc. FDA Presentation ODAC Meeting

Add to Reading List

Source URL: www.fda.gov

Language: English
UPDATE